Linear focal elastosis or elastotic striae is a skin condition that presents with asymptomatic, palpable or atrophic, yellow lines of the middle and lower back, thighs, arms and breasts. See also
Skin lesion

References


== External links ==
History
Brinzolamide/brimonidine was approved for medical use in the United States in April 2013, and in the European Union in July 2014. References
Further reading
Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, Wormald R, Dickersin K (January 2016). "Comparative Effectiveness of First-Line Medications for Primary Open-Angle Glaucoma: A Systematic Review and Network Meta-analysis". Ophthalmology. 123 (1): 129–40. doi:10.1016/j.ophtha.2015.09.005. PMC 4695285. PMID 26526633. Lusthaus JA, Goldberg I (September 2017). "Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation". Expert Opin Drug Saf. 16 (9): 1071–1078. doi:10.1080/14740338.2017.1346083. PMID 28656780. S2CID 205825340. External links
"Brinzolamide". Drug Information Portal. U.S. National Library of Medicine. "Brimonidine". Drug Information Portal. U.S. National Library of Medicine. "Brimonidine tartrate". Drug Information Portal. U.S. National Library of Medicine.